261.51
Iqvia Holdings Inc stock is traded at $261.51, with a volume of 1.27M.
It is up +0.81% in the last 24 hours and up +25.70% over the past month.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
See More
Previous Close:
$259.42
Open:
$254.91
24h Volume:
1.27M
Relative Volume:
0.84
Market Cap:
$43.04B
Revenue:
$16.63B
Net Income/Loss:
$1.39B
P/E Ratio:
32.42
EPS:
8.0674
Net Cash Flow:
$2.12B
1W Performance:
+4.91%
1M Performance:
+25.70%
6M Performance:
+53.25%
1Y Performance:
+39.28%
Iqvia Holdings Inc Stock (IQV) Company Profile
Name
Iqvia Holdings Inc
Sector
Industry
Phone
919-998-2000
Address
2400 ELLIS ROAD, DURHAM, NC
Compare IQV vs TMO, DHR, NTRA, A, IDXX
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
IQV
Iqvia Holdings Inc
|
261.51 | 42.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
|
TMO
Thermo Fisher Scientific Inc
|
633.71 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
215.36 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
NTRA
Natera Inc
|
338.45 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
|
A
Agilent Technologies Inc
|
155.08 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
|
IDXX
Idexx Laboratories Inc
|
553.44 | 43.00B | 4.45B | 1.10B | 1.06B | 13.59 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-09-26 | Upgrade | TD Cowen | Hold → Buy |
| Mar-06-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-03-26 | Initiated | RBC Capital Mkts | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Nov-03-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-29-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-09-25 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-09-25 | Upgrade | Jefferies | Hold → Buy |
| Apr-25-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-10-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-03-25 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-20-24 | Initiated | Stephens | Overweight |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-04-24 | Initiated | RBC Capital Mkts | Outperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| Jun-06-24 | Initiated | Goldman | Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-15-24 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-13-24 | Initiated | BTIG Research | Buy |
| Nov-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Mar-17-23 | Initiated | Truist | Buy |
| Dec-06-22 | Initiated | Cowen | Outperform |
| Nov-17-22 | Downgrade | Citigroup | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-29-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-16-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-08-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jul-07-20 | Initiated | Stephens | Equal-Weight |
| Mar-02-20 | Initiated | Deutsche Bank | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Dec-13-19 | Upgrade | CFRA | Sell → Hold |
| Nov-14-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-21-19 | Upgrade | Mizuho | Neutral → Buy |
| May-28-19 | Initiated | SVB Leerink | Outperform |
| Jan-18-19 | Upgrade | Jefferies | Hold → Buy |
| Oct-09-18 | Initiated | UBS | Buy |
| Oct-02-18 | Reiterated | Robert W. Baird | Outperform |
| Jul-25-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-25-18 | Reiterated | Stifel | Buy |
| Jul-03-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-13-18 | Upgrade | Goldman | Neutral → Buy |
| Mar-07-18 | Upgrade | SunTrust | Hold → Buy |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
View All
Iqvia Holdings Inc Stock (IQV) Latest News
IQVIA Holdings Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Iqvia Holdings stock hits 52-week high at $260.32 - Investing.com
Iqvia Holdings stock hits 52-week high at $260.32 By Investing.com - Investing.com India
IQVIA Holdings | 8-K: IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance - Moomoo
IQVIA Holdings Stock Outlook: Is Wall Street Bullish or Bearish? - inkl
9,249 Shares in IQVIA Holdings Inc. $IQV Purchased by Wealthfront Advisers LLC - MarketBeat
IQVIA Holdings stock trades close to 52 week high as recent earnings and outlook support elevated va - Ad-hoc-news.de
Danske Bank A S Takes $14.21 Million Position in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
MULTI-MANAGER HIGH YIELD OPPORTUNITY FUND's IQVIA Holdings Inc(IQV) Holding History - GuruFocus
IQVIA stock holds near a 52 week high - Ad-hoc-news.de
IQVIA (NYSE:IQV) Reaches New 1-Year HighTime to Buy? - MarketBeat
Edmond DE Rothschild Holding S.A. Purchases New Position in IQVIA Holdings Inc. $IQV - MarketBeat
Deutsche Bank AG Buys Shares of 740,473 IQVIA Holdings Inc. $IQV - MarketBeat
BlackRock Inc. Takes Position in IQVIA Holdings Inc. $IQV - MarketBeat
A Look at IQVIA Holdings Inc (IQV) After 3.9% Gain -- GF Value $247.09 vs Price $249.28 - GuruFocus
Mitsubishi UFJ Asset Management Co. Ltd. Takes $78.51 Million Position in IQVIA Holdings Inc. $IQV - MarketBeat
227,555 Shares in IQVIA Holdings Inc. $IQV Bought by Danica Pension Livsforsikringsaktieselskab - MarketBeat
Bruni J V & Co. Co. Purchases New Shares in IQVIA Holdings Inc. $IQV - MarketBeat
Act Two Investors LLC Invests $30.67 Million in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings Inc (IQV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IQVIA Holdings Inc (HAM:QTS) Stock Price, Trades & News - GuruFocus
Pallas Capital Advisors LLC Acquires New Shares in IQVIA Holdings Inc. $IQV - MarketBeat
Plato Investment Management Ltd Invests $1.34 Million in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings Company Profile & Introduction - Moomoo
Global Retirement Partners LLC Purchases Shares of 7,179 IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group - Yahoo Finance
IQVIA Holdings stock steadies above $230 as Q2 2026 growth and guidance support outlook - AD HOC NEWS
10,831 Shares in IQVIA Holdings Inc. $IQV Purchased by OneDigital Investment Advisors LLC - MarketBeat
Nippon Life Global Investors Americas Inc. Purchases Shares of 4,300 IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings, Inc. (IQV) Stock Analysis: A Strong Buy With 16.27% Upside Potential - DirectorsTalk Interviews
Focus Partners Advisor Solutions LLC Acquires New Shares in IQVIA Holdings Inc. $IQV - MarketBeat
SFE Investment Counsel Invests $11.41 Million in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings (IQV) Reported Record Bookings And Raised Guidance, Is It Now Overvalued? - Sahm
IQVIA Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
IQV|IQVIA Holdings Inc|Price:241.330|Chg%:+4.670 - TradingKey
IQVIA Holdings (IQV) Q1 2026 Earnings Call Transcript - Fortune
IQVIA Holdings stock trades around $242 as investors weigh recent earnings trend - AD HOC NEWS
LECAP ASSET MANAGEMENT LTD's IQVIA Holdings Inc(IQV) Holding History - GuruFocus
IQVIA Holdings Inc. (IQV) Stock Price, News, Quote & History - Yahoo! Finance Canada
IQV Stock Gains 42% in 3 Months: Here's What You Should Know - TradingView
IQVIA Holdings Inc (IQV) GF Score of 94/100: A Signal of Strong Outperformance Potential - GuruFocus
NewEdge Advisors LLC Increases Stock Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
(IQV) Volatility Zones as Tactical Triggers - Stock Traders Daily
IQVIA Holdings, Inc. (IQV) Stock Analysis: Investor Outlook With A 15% Potential Upside - DirectorsTalk Interviews
IQVIA Holdings Inc (IQV) Stock News Today - TradingKey
IQVIA Holdings Inc. (IQV) stock price, news, quote and history - Yahoo Finance Singapore
How IQVIA’s Medera Cardiac Gene Therapy Alliance and Raised 2026 Outlook Will Impact IQV (IQV) Investors - simplywall.st
How Investors Are Reacting To IQVIA Holdings (IQV) Cardiac Gene Therapy Push And Higher 2026 Revenue Outlook - Yahoo Finance
Oliver Luxxe Assets LLC Acquires Shares of 18,573 IQVIA Holdings Inc. $IQV - MarketBeat
Legacy Wealth Management LLC MS Sells 8,935 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Iqvia Holdings Inc Stock (IQV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):